Previously, we showed that AMPK-mediated mTOR signaling inhibition induced aberrant ROS accumulation, causing defects in the oxidative machinery and mitochondrial membrane potential in lung and bladder cancer cells [21,22]. Here, MTOR is linked to urinary bladder cancer.